Skip to main content

Furosemide News

Heart Failure Patients Increase Their Odds Of Death By Skipping Yearly Doctor Visit

TUESDAY, May 20, 2025 — Two out of 5 people with heart failure are more likely to die because they aren’t regularly seeing a cardiologist, a new study says. The 3 in 5 heart failure patients who do se...

scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the Furoscix Indication to Include the Treatment of Edema in Patients with Chronic Kidney Disease

BURLINGTON, Mass., March 06, 2025 (GLOBE NEWSWIRE) – scPharmaceuticals Inc. (Nasdaq: SCPH) (the “Company”), a pharmaceutical company committed to revolutionizing cardiorenal healthcare through pat...

scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the Furoscix Indication in Heart Failure

Furoscix is now indicated for the treatment of congestion due to fluid overload in adult patients with chronic heart failure, regardless of New York Heart Association (NYHA) functional class...

FDA Approves Furoscix (furosemide injection) for the At-Home Treatment of Congestion Due to Fluid Overload in Chronic Heart Failure

Furoscix demonstrated 99.6% bioavailability and produced similar diuresis and natriuresis compared to intravenous furosemide BURLINGTON, Mass., Oct. 10, 2022 (GLOBE NEWSWIRE) – scPharmaceuticals...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Edema, Heart Failure, Congestive Heart Failure, High Blood Pressure, Hypertension, Chronic Kidney Disease, Renal Failure

Related drug support groups

Lasix

Furosemide patient information at Drugs.com